PROM1 and hepatocellular carcinoma: miR-142-3p expression was not found to correlate with another clinicopathological feature (Supplementary Table 1); but is inversely correlated with CD133 expression in HCC where we and others have previously reported CD133 to be preferentially expressed in HCC, but is detected at only low or absent levels in non-tumor liver tissues [3].